Hookipa Pharma Inc (HOOK)
US Market

Hookipa Pharma (HOOK) Stock Price & Analysis


HOOK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.68 - $2.05
Previous Close$1.31
Average Volume (3M)898.58K
Market Cap
Enterprise Value-$27.78M
Total Cash (Recent Filing)$109.60M
Total Debt (Recent Filing)$5.76M
Price to Earnings (P/E)-1.3
Aug 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding54,722,339
10 Day Avg. Volume1,343,284
30 Day Avg. Volume898,579
Standard Deviation0.21
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.05
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.74
Enterprise Value/Gross Profit-1.95
Enterprise Value/Ebitda0.40
Price Target Upside383.18% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Hookipa Pharma Inc’s price range in the past 12 months?
Hookipa Pharma Inc lowest stock price was $0.68 and its highest was $2.05 in the past 12 months.
    What is Hookipa Pharma Inc’s market cap?
    Currently, no data Available
    When is Hookipa Pharma Inc’s upcoming earnings report date?
    Hookipa Pharma Inc’s upcoming earnings report date is Aug 16, 2023 which is in 76 days.
      How were Hookipa Pharma Inc’s earnings last quarter?
      Hookipa Pharma Inc released its earnings results on May 11, 2023. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.226 by -$0.044.
        Is Hookipa Pharma Inc overvalued?
        According to Wall Street analysts Hookipa Pharma Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Hookipa Pharma Inc pay dividends?
          Hookipa Pharma Inc does not currently pay dividends.
          What is Hookipa Pharma Inc’s EPS estimate?
          Hookipa Pharma Inc’s EPS estimate is -$0.25.
            How many shares outstanding does Hookipa Pharma Inc have?
            Hookipa Pharma Inc has 52,322,823 shares outstanding.
              What happened to Hookipa Pharma Inc’s price movement after its last earnings report?
              Hookipa Pharma Inc reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.226. Following the earnings report the stock price went up 1.075%.
                Which hedge fund is a major shareholder of Hookipa Pharma Inc?
                Among the largest hedge funds holding Hookipa Pharma Inc’s share is Baker Bros Advisors LP. It holds Hookipa Pharma Inc’s shares valued at 3M.


                  Hookipa Pharma Stock Smart Score

                  The Hookipa Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Hookipa Pharma Inc

                  HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary its arenavirus platform that is designed to reprogram the body's immune system. Its product include VaxWace, a replication-deficient viral vector; and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8+ T cells and pathogen-neutralizing antibodies. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.


                  Top 5 ETFs holding HOOK

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold HOOK. The ETFs are listed according to market value of HOOK within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adverum Biotechnologies
                  Crispr Therapeutics AG
                  Editas Medicine
                  G1 Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis